Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer
ACS Nano · 2026
DOI: 10.1021/acsnano.6c08006 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2026. Verfasst von Yali Zhuang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Nansha, Guangzhou 511400, China. Hauptthemen laut MEDLINE: Immunotherapy, Colonic Neoplasms, Arginine, Ovalbumin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Bioscience and Biomedical Engineering Thrust, The Hong Kong University of Science and Technology (Guangzhou), Nansha, Guangzhou 511400, China.
- State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center…
- Department of Anesthesiology, General Hospital of Southern Theatre Command of PLA, Guangzhou 510010, China.
- Department of Hematology, the Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, China.
- Center for Nanomedicine and Department of Anesthesiology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts 02115, United States.
- Division of Life Science, the Hong Kong University of Science and Technology, Hong Kong, SAR 999077, China.
ORCID-Profile: Jun Wu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Zhuang, Y., Wang, L., Xie, C., Yang, R., Li, M., Dai, C., Di, Y., Yuan, M., Tong, T., Zhang, T., You, X., Xia, X., & Wu, J. (2026). Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer. ACS Nano. https://doi.org/10.1021/acsnano.6c08006
Vancouver
Zhuang Y, Wang L, Xie C, Yang R, Li M, Dai C, et al. Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer. ACS Nano. 2026. doi:10.1021/acsnano.6c08006
BibTeX
@article{Zhuang2026,
author = {Zhuang, Yali and Wang, Liying and Xie, Chunyuan and Yang, Ruoxi and Li, Minghui and Dai, Chunlei and Di, Yongxiang and Yuan, Mengfang and Tong, Tong and Zhang, Tianren and You, Xinru and Xia, Xiaojun and Wu, Jun},
title = {Arginine Polymer-Based Nanoplatform Facilitates Oral Co-Delivery of Antibody/Antigen for Robust Oral Immunotherapy in Orthotopic Colon Cancer},
journal = {ACS Nano},
year = {2026},
doi = {10.1021/acsnano.6c08006}
}
EUVIMED